Improved primary transplant success rates using a triple regimen of cyclosporine microemulsion, mycophenolate mofetil and prednisone.
Khauli
R B
RB
Departments of Surgery, American University Medical Center, Beirut, Lebanon.
Medawar
W A
WA
Habbal
A A
AA
Birbari
A E
AE
Daouk
M M
MM
Abdelnoor
A M
AM
Uwaydah
M
M
Rahman Bizri
A
A
Sanjad
S
S
Ayvazian
P J
PJ
Lovewell
T
T
Stoff
J S
JS
Yang Fan
P
P
Bigwood
P
P
Harland
R
R
D000208:Acute Disease; D000212:Acyclovir / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D002102:Cadaver; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000188:drug therapy; D004359:Drug Therapy, Combination; D004655:Emulsions; D006084:Graft Rejection / Q000188:drug therapy; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D019520:Living Donors; D016853:Muromonab-CD3 / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use*; D012086:Reoperation / Q000706:statistics & numerical data; D013997:Time Factors; D016896:Treatment Outcome
D000998:Antiviral Agents; D004655:Emulsions; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D009173:Mycophenolic Acid; D011241:Prednisone; D000212:Acyclovir